0001123292-16-001556.txt : 20160113 0001123292-16-001556.hdr.sgml : 20160113 20160113170548 ACCESSION NUMBER: 0001123292-16-001556 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160111 FILED AS OF DATE: 20160113 DATE AS OF CHANGE: 20160113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Fred E CENTRAL INDEX KEY: 0001339358 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 161341270 MAIL ADDRESS: STREET 1: 301 COMMERCE STREET STREET 2: SUITE 3300 CITY: FORT WORTH STATE: TX ZIP: 76102 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-01-11 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001339358 Cohen Fred E C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2016-01-11 4 M 0 4065 8.49 A 4177 D Common Stock 2016-01-11 4 M 0 4065 5.54 A 8242 D Common Stock 2016-01-11 4 M 0 4065 7.26 A 12307 D Common Stock 2016-01-11 4 M 0 12500 12.70 A 24807 D Stock Option (right to buy) 8.49 2016-01-11 4 M 0 4065 0 D 2021-07-13 Common Stock 4065 0 D Stock Option (right to buy) 5.54 2016-01-11 4 M 0 4065 0 D 2022-07-10 Common Stock 4065 0 D Stock Option (right to buy) 7.26 2016-01-11 4 M 0 4065 0 D 2023-07-18 Common Stock 4065 0 D Stock Option (right to buy) 12.70 2016-01-11 4 M 0 12500 0 D 2024-05-15 Common Stock 12500 0 D This option is fully vested and immediately exercisable. /s/ Francis Sarena, Attorney-in-Fact 2016-01-13